Resorcinol peels as a possible self‐treatment of painful nodules in hidradenitis suppurativa

  title={Resorcinol peels as a possible self‐treatment of painful nodules in hidradenitis suppurativa},
  author={Jurr Boer and Gregor B. E. Jemec},
  journal={Clinical and Experimental Dermatology},
  • J. Boer, G. Jemec
  • Published 1 January 2010
  • Medicine
  • Clinical and Experimental Dermatology
BACKGROUND Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by abscess formation localized to apocrine sweat gland-bearing skin. [] Key MethodMETHODS The case notes of 12 women with stage 1 or 2 HS treated with topical resorcinol and followed up for at least 1 year were reviewed.

Dissecting cellulitis of the scalp successfully treated with topical resorcinol 15%

Dissecting cellulitis is an inflammatory, chronic, and recurrent disease of the hair follicle and some authors suggest an important role of the neutrophils and the inflammatory via interlekin-1.

Long‐term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?

The once-in-a-lifetime use of oral isotretinoin in the treatment of Hidradenitis suppurativa is suggested to be a viable option for the management of the disease.

Current and future treatments of hidradenitis suppurativa

Key areas of different treatment options for hidradenitis suppurativa have been addressed and outlined in this review.

Pilonidal sinus: clinical and ultrasonographic response to topical resorcinol 15%

Pilonidal sinus is a common recurrent disease, often inflamed, usually located on sacral area, and causing high levels of morbidity and mortality in men.

Hidradenitis suppurativa: Topical and intralesional treatment options

Topical and intralesional therapies for the management of HS are discussed, characterized by inflammation of the pilosebaceous glands in skin complicated by the formation of abscesses, sinus tracts, and scarring.

Efficacy and safety of topical resorcinol 15% as long‐term treatment of mild‐to‐moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance

Antibiotics represent the first line treatment in the management of HS primarily for their anti-inflammatory properties, with additional contributions via antimicrobial and immunomodulatory effects.

Improving quality of life in patients with hidradenitis suppurativa: a therapeutic view

The literature is limited but indicates that there are two ways of improving patients’ QoL: therapy of the somatic disease or psychosocial interventions.

Hidradenitis suppurativa for the nondermatology clinician

This article synthesizes for the nondermatology clinician the evidence for various HS treatments, along with the diagnostic and therapeutic guidelines for HS published by the British Association of Dermatologists, US and Canadian HS Foundations, HS ALLIANCE, Canadian Dermatology Association, and Brazilian Society ofDermatology.

Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients

Hidradenitis suppurativa is a chronic inflammatory skin disorder of the follicular epithelium that is associated with rheumatoid arthritis and central giant cell granuloma.



Morbidity in patients with hidradenitis suppurativa

This work has shown that quality‐of‐life measures may be a relevant surrogate measure of skin disease and may form a pertinent measure of disease severity in Hidradenitis suppurativa.

Hidradenitis suppurativa ‐ characteristics and consequences

The general characteristics of the disease and its impact on patients with an established diagnosis of hidradenitis suppurativa are described and those of an unselected general population sample are compared.

Topical Treatment of Hidradenitis Suppurativa with Clindamycin

The overall effect of clindamycin treatment based on patients' assessments, number of abscesses, inflammatory nodules and pustules was significantly better than placebo at each monthly evaluation (P < 0.01).

Medical treatment of hidradenitis suppurativa

  • G. Jemec
  • Medicine, Biology
    Expert opinion on pharmacotherapy
  • 2004
Preceiving HS as an inflammatory skin disease suggests the use of general immunosuppressive drugs in the treatment of this condition and this approach, using both traditional immunosupressants and monoclonal antibodies, appears to have some potential.

The natural history of hidradenitis suppurativa

The objective is to investigate aspects of the natural history of hidradenitis that are unknown in the wild and investigate its role in human disease.

Chemical peeling: How, when, why?

In the present study the characteristics of the individual substances, technical procedure, and applications are taken into consideration, and the main risks and side-effects, depending on the depth of peeling, are considered.

Confusion after topical use of resorcinol.

A 28-year-old woman without a neurologic history was treated for 3 days for acne vulgaris involving the entire back with the following preparation: resorcinol; she presented with confusion, postcritical amnesia, and tremors; she was disoriented and had vacant stare, but no clonism.